In light of these results, the high TUC concentrations needed to achieve significant anti-neoplastic activity in CRC and NSCLC cells may not only be the result of low HER2 expression levels but also indicate an important role of additional driver and resistance mechanisms in these entities. Here, ERBB2 is linked to non-small cell lung carcinoma.